This inventor holds 10 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: National Institute of Health and Medical Research, Centre National De La Recherche Scientifique, Immunotech. Active years: 1998-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nantes Cedex, FR (1998)
- Vertou, FR (2003 - 2012)
- Nantes, FR (2020)
Company Filing History:
9 out of 1,853 
2 out of 5,383 
1 out of 17 
Years Active: 1998-2020
Title: Marc Bonneville: Innovator in Immunology
Introduction
Marc Bonneville is a prominent inventor based in Vertou, France. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 10 patents, Bonneville's work focuses on enhancing the understanding and treatment of immune responses.
Latest Patents
Among his latest patents, Bonneville has developed anti-CD277 antibodies. These antibodies are designed to activate or inhibit the cytolytic function of Vγ9/Vδ2 T cells. They also have the potential to costimulate T cells in conjunction with CD3-TCR and CD28-B7 costimulation. Additionally, these antibodies can increase the activity and survival of monocytes and dendritic cells, showcasing their therapeutic potential. Another notable invention involves the means for detection and purification of CD8+ T lymphocyte populations specific to peptides presented in the context of HLA. This invention utilizes multimers developed from recombinant protein analogues of MHC class I.
Career Highlights
Marc Bonneville has worked with esteemed organizations such as the National Institute of Health and Medical Research and the Centre National de la Recherche Scientifique. His career reflects a commitment to advancing scientific knowledge and improving therapeutic strategies in immunology.
Collaborations
Throughout his career, Bonneville has collaborated with notable colleagues, including Christian Belmant and Jean-Jacques Fournie. These partnerships have contributed to the success of his research and innovations.
Conclusion
Marc Bonneville's contributions to immunology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence therapeutic approaches and enhance our understanding of immune responses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile